These findings suggest that, in contrast to de novo CHL, CHL-IDD may involve pathological mechanisms that depend on other mechanisms, along with the amplification of 9p24.1, which contains the CD274 region that encodes PD-L1. Here, CD274 is linked to classic Hodgkin lymphoma.